Zhengrick-Pama, a strategic acquisition to boost clinical supply capacity in China.

Summary

With the addition of new facilities with drug distribution licenses to support clinical trials in China, Zullig Pharma has announced that it has strategically acquired its own supply facility for clinical trial supplies located in China.